Article Data

  • Views 415
  • Dowloads 114

Original Research

Open Access

Decreased expression of SIRT6 promotes tumor cell growth correlates closely with poor prognosis of ovarian cancer

  • G. Zhang1
  • Z. Liu1
  • S. Qin2
  • K. Li2,3,*,

1Department of Gynaecology and Obstetrics, Affiliated Qianfoshan Hospital of Shandong University, Jinan city, China

2Institute of Materia Media, Shandong Academy of Medical Sciences, Jinan city, China

3Department of Gynaecology and Obstetrics, Affiliated Hospital of Shandong Academy of Medical Sciences, Jinan city, China

DOI: 10.12892/ejgo2627.2015 Vol.36,Issue 6,December 2015 pp.629-632

Published: 10 December 2015

*Corresponding Author(s): K. Li E-mail: kunli3448@gmail.com

Abstract

Introduction: Cancer is a group of diseases characterized by uncontrolled growth and spread of abnormal cells. If the spread is not controlled, it can result in death. Sirtunins belong to a protein family and it is present in all organisms. SIRT6 is downregulated in tumor and acts as tumor suppressor. These sirtunin proteins are linked to repair DNA and metabolism. Material and Methods: To measure the role of SIRT6 in tumor cell, 20 mice were used and European Collection of Cell Cultures (ECACC) cell lines were used for the analysis. A histopathological technique showed the level of tumor cells. Results: A recent study provided exceptional insight into the mechanism of SIRT6-related chromatin regulation. According to the histopathology of cancer, SIRT1 localizes to the promoters of several aberrantly silenced tumor suppressor genes whose DNA is hypermethylated. SIRT1 has a role associated with the epigenetic hallmarks of cancer. Conclusion: The link between SIRT6 and cancer provide new insight into the therapeutic potential of small molecule activators or specific targets of SIRT6 for the prevention and treatment of cancer. Further investigation into the specific mechanism of SIRT6 is required to realize this potential.

Keywords

Ovarian cancer; SIRT6 expression; Sirtunins.

Cite and Share

G. Zhang,Z. Liu,S. Qin,K. Li. Decreased expression of SIRT6 promotes tumor cell growth correlates closely with poor prognosis of ovarian cancer. European Journal of Gynaecological Oncology. 2015. 36(6);629-632.

References

[1] Rine, J. N. Strathern, J. B. Hicks, Herskowitz I.: “A suppressor ofmating- type locus mutations in Saccharomyces cerevisiae: evidence for and identification of cryptic matingtype loci,” Genetics, 1979, 93, 877.

[2] Albani, L. Polito, G. Forloni: “Sirtuins as novel targets for Alzheimer’s disease and other neurodegenerative disorders: experimental and genetic evidence”. J. Alzheimers Dis., 2010, 19, 11.

[3] Esteves A.R., Lu J., Rodova M., Onyango I., Lezi E., Dubinsky R., Lyons K.E., et al.: “Mitochondrial respiration and respiration-associated proteins in cell lines created through Parkinson’s subject mitochondrial transfer” J. Neurochem., 2010, 113, 674.

[4] Schumacker T.: “A tumor suppressor SIRTainty.” Cancer Cell, 2010, 17, 5.

[5] Haigis M.C., Sinclair D.A.: “Mammalian sirtuins: biological insights and disease relevance”. Annu. Rev. Pathol., 2010, 5, 253.

[6] Dali-Youcef N., Lagouge M., Froelich S., Koehl C., Schoonjans K., Auwerx J.: “Sirtuins: the ’magnificent seven’, function, metabolism and longevity”. Ann. Med., 2007, 39, 335.

[7] Qiu X., Brown K.V., Moran Y., Chen D.: “Sirtuin regulation in calo-rie restriction”. Biochim. Biophys. Acta, 2010, 1804, 1576.

[8] Ghosh S., George S., Roy U., Ramachandran D., Kolthur-Seetharam U.: “NAD: a master regulator of transcription”. Biochim. Biophys. Acta, 2010, 1799, 681.

[9] Frye R.A.: “Phylogenetic classification of prokaryotic and eukaryotic Sir2-like proteins”. Biochem. Biophys. Res. Commun., 2000, 273, 793.

[10] Huang J.Y., Hirschey M.D., Shimazu T., Ho L., Verdin E.: “Evolu-tionarily conserved and nonconserved cellular localizations and func-tions of human SIRT proteins”. Mol. Biol. Cell, 2005, 16, 4623.

[11] Huang M.,Hirschey, T. Shimazu, L.Ho, and E. Verdin, “Mitochon-drial sirtuins”. Biochim. Biophys. Acta, 2010, 1804, 1645.

[12] North B.J., Verdin E.: “Interphase nucleo-cytoplasmic shuttling and localization of SIRT2 during mitosis”. PLoS One, 2007, 2, e784.

[13] Tanno M., Sakamoto J., Miura T., Shimamoto K., Horio Y.: “Nucle-ocytoplasmic shuttling of the NAD+- dependent histone deacetylase SIRT1”. J. Biol. Chem., 2007, 282, 6823.

[14] Deng C.X.: “SIRT1, is it a tumor promoter or tumor suppressor?” Int. J. Biol. Sci., 2009, 5, 147.

[15] Inoue T., Hiratsuka M., Osaki M., Yamada H., Kishimoto I., Yam-aguchi S., et al.: “SIRT2, a tubulin deacetylase, acts to block the entry to chromosome condensation in response to mitotic stress”. Oncogene, 2007, 26, 945.

[16] Belenky P., Christensen K.C., Gazzaniga F., Pletnev A.A., Brenner C.: “Nicotinamide riboside and nicotinic acid riboside salvage in fungi and mammals quantitative basis for urh1 and purine nucleoside phospho-rylase function in NAD+ metabolism”. J. Biol. Chem., 2009, 284, 158.

[17] McCord R.A., Michishita E., Hong T., Berber E., Boxer L.D., Kusumoto R., et al.: “SIRT6 stabilizes DNA-dependent protein ki-nase at chromatin for DNA double-strand break repair.” Aging (Al-bany NY), 2009, 1, 109.

[18] Mostoslavsky R., Chua K.F., Lombard D.B., Pang W.W., Fischer M.R., Gellon L., et al.: “Genomic instability and aging-like phenotype in the absence of mammalian SIRT6”. Cell, 2006, 124, 315.

[19] Ma W., Stafford L.J., Li D., Luo J., Li X., Ning G., Liu M.:“GCIP/CCNDBP1, a helix-loop-helix protein, suppresses tumorigenesis”. J. Cell. Biochem., 2007, 100, 1376.

[20] Kamel C., Abrol M., Jardine K., He X., McBurney M.W.: “SirT1failstoaffectp53-mediated biologicalfunctions”. Aging Cell, 2006, 5, 81.

[21] Deng C.X.: “SIRT1, isitatumor promoterortumorsuppressor?” Int. J. Biol. Sci., 2009, 5, 147.

[22] Ashraf N., Zino S., Macintyre A., Kingsmore D., Payne A.P., George W.D., Shiels P.G.: “Alteredsirtuinexpression is associatedwithnodepositive breastcancer:. Br. J. Cancer, 2006, 95, 1056.

[23] Dang C.V.: “MYC on the path to cancer”. Cell, 2012, 149, 22.

[24] DeBerardinis R.J., Lum J.J., Hatzivassiliou G., Thompson C.B.: “The biology of cancer: metabolic reprogramming fuels cell growth and proliferation”. Cell Metab., 2008, 7, 11.

Abstracted / indexed in

Science Citation Index Expanded (SciSearch) Created as SCI in 1964, Science Citation Index Expanded now indexes over 9,500 of the world’s most impactful journals across 178 scientific disciplines. More than 53 million records and 1.18 billion cited references date back from 1900 to present.

Biological Abstracts Easily discover critical journal coverage of the life sciences with Biological Abstracts, produced by the Web of Science Group, with topics ranging from botany to microbiology to pharmacology. Including BIOSIS indexing and MeSH terms, specialized indexing in Biological Abstracts helps you to discover more accurate, context-sensitive results.

Google Scholar Google Scholar is a freely accessible web search engine that indexes the full text or metadata of scholarly literature across an array of publishing formats and disciplines.

JournalSeek Genamics JournalSeek is the largest completely categorized database of freely available journal information available on the internet. The database presently contains 39226 titles. Journal information includes the description (aims and scope), journal abbreviation, journal homepage link, subject category and ISSN.

Current Contents - Clinical Medicine Current Contents - Clinical Medicine provides easy access to complete tables of contents, abstracts, bibliographic information and all other significant items in recently published issues from over 1,000 leading journals in clinical medicine.

BIOSIS Previews BIOSIS Previews is an English-language, bibliographic database service, with abstracts and citation indexing. It is part of Clarivate Analytics Web of Science suite. BIOSIS Previews indexes data from 1926 to the present.

Journal Citation Reports/Science Edition Journal Citation Reports/Science Edition aims to evaluate a journal’s value from multiple perspectives including the journal impact factor, descriptive data about a journal’s open access content as well as contributing authors, and provide readers a transparent and publisher-neutral data & statistics information about the journal.

Submission Turnaround Time

Conferences

Top